Tianjin Chase Sun Pharmaceutical Co Ltd (300026) — Working Capital to Net Assets Ratio
Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Working Capital to Net Assets ratio of 51.8% as of March 2026. Working capital of CN¥4.52 Billion (current assets of CN¥5.74 Billion minus current liabilities of CN¥1.22 Billion) is measured against net assets of CN¥8.72 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See net asset quality index of Tianjin Chase Sun Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Tianjin Chase Sun Pharmaceutical Co Ltd Working Capital to Net Assets (2006–2024)
This chart shows how Tianjin Chase Sun Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2006 to 2024. As of March 2026, the ratio stands at 51.8%, reflecting working capital of CN¥4.52 Billion against net assets of CN¥8.72 Billion CNY. Check Tianjin Chase Sun Pharmaceutical Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 300026 stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 51.5% | CN¥4.53 Billion | CN¥8.80 Billion | CN¥6.15 Billion | CN¥1.62 Billion | ▼ -6.7 pp |
| 2023 | 58.1% | CN¥5.16 Billion | CN¥8.87 Billion | CN¥6.72 Billion | CN¥1.56 Billion | ▲ +2.5 pp |
| 2022 | 55.6% | CN¥4.71 Billion | CN¥8.46 Billion | CN¥7.39 Billion | CN¥2.68 Billion | ▼ -4.1 pp |
| 2021 | 59.7% | CN¥4.75 Billion | CN¥7.95 Billion | CN¥6.81 Billion | CN¥2.06 Billion | ▲ +14.1 pp |
| 2020 | 45.6% | CN¥3.37 Billion | CN¥7.39 Billion | CN¥5.71 Billion | CN¥2.34 Billion | ▲ +1.9 pp |
| 2019 | 43.8% | CN¥3.09 Billion | CN¥7.07 Billion | CN¥4.33 Billion | CN¥1.23 Billion | ▼ -3.0 pp |
| 2018 | 46.8% | CN¥3.08 Billion | CN¥6.58 Billion | CN¥3.91 Billion | CN¥836.85 Million | ▲ +1.7 pp |
| 2017 | 45.1% | CN¥2.93 Billion | CN¥6.51 Billion | CN¥3.81 Billion | CN¥874.78 Million | ▲ +0.4 pp |
| 2016 | 44.7% | CN¥2.70 Billion | CN¥6.04 Billion | CN¥3.90 Billion | CN¥1.20 Billion | ▼ -2.6 pp |
| 2015 | 47.2% | CN¥2.50 Billion | CN¥5.29 Billion | CN¥3.64 Billion | CN¥1.14 Billion | ▼ -8.7 pp |
| 2014 | 56.0% | CN¥1.32 Billion | CN¥2.36 Billion | CN¥1.98 Billion | CN¥660.65 Million | ▲ +7.0 pp |
| 2013 | 49.0% | CN¥834.02 Million | CN¥1.70 Billion | CN¥1.31 Billion | CN¥474.81 Million | ▲ +2.7 pp |
| 2012 | 46.3% | CN¥641.98 Million | CN¥1.39 Billion | CN¥980.05 Million | CN¥338.07 Million | ▼ -8.8 pp |
| 2011 | 55.0% | CN¥578.01 Million | CN¥1.05 Billion | CN¥845.59 Million | CN¥267.58 Million | ▼ -16.8 pp |
| 2010 | 71.9% | CN¥789.08 Million | CN¥1.10 Billion | CN¥962.17 Million | CN¥173.09 Million | ▼ -12.6 pp |
| 2009 | 84.5% | CN¥782.80 Million | CN¥926.88 Million | CN¥903.18 Million | CN¥120.38 Million | ▲ +72.6 pp |
| 2008 | 11.9% | CN¥14.90 Million | CN¥125.51 Million | CN¥101.92 Million | CN¥87.02 Million | ▲ +23.5 pp |
| 2007 | -11.6% | CN¥-7.13 Million | CN¥61.24 Million | CN¥103.22 Million | CN¥110.35 Million | ▲ +170.2 pp |
| 2006 | -181.8% | CN¥-38.69 Million | CN¥21.28 Million | CN¥45.65 Million | CN¥84.34 Million | — |